CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01746108
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:14.422469+00:00
Published At: 2017-01-09T00:00:00+00:00
Record Updated At: 2019-07-09
Results Posted At: 2017-01-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Streptococcal", "Streptococcus Pneumoniae Vaccines"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-07-09"
protocolSection.identificationModule.nctId: "NCT01746108"
protocolSection.identificationModule.officialTitle: "Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals\u0027 Pneumococcal Vaccine (Synflorix\u2122) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-01-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.